CAR-CLDN18.2-γδ T cells and CAR-CLDN18.2-αβ T cells significantly inhibited the growth of tumors (Figure 6C–E) and prolonged the survival of tumor-bearing mice (Figure 6F) compared with PBS and vector control cells. Here, CLDN18 is linked to neoplasm.